Clinical trials that explore the repurposing of drugs for off-label uses are common, but without a commitment to rigorously testing the hypotheses generated by these exploratory trials, drugs used off-label are costly and may be ineffective. Ethics committees should devise measures that encourage coupling of exploratory testing with confirmatory trials. (British Medical Journal)